Nailon, Jielo .

HRN: 21-81-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
METRONIDAZOLE 500MG (TAB)
08/14/2022
08/20/2022
ORAL
500mg
TID X 7 Days
LBM
Waiting Final Action 
08/14/2022
CEFTRIAXONE 1G (VIAL)
08/14/2022
08/20/2022
IVTT
2.0
Q12 X 7 Days
Lbm
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: